RxDoctor Payments Data

Jahangir Sharifi, MD

Otolaryngology/Facial Plastic Surgery · Los Angeles, CANPI 1457422065

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Optinose US, Inc. at 40.1% of the total. Reporting peaked in 2019 at $4,496 and has fallen 68.1% since, to $1,435 in 2025. Among otolaryngology/facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,031in general payments, 2019–2025

Across 185 payments — averaging $65.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$5K
  • Medtronic$3K
  • Inspire Medical Systems, Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$710
  • GSK$524
  • Sanofi$461
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$3,00025%
  • Travel & lodging$2,54821%
  • Food & beverage$6,48354%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,031 in reported general payments places this provider in the 90th percentile of 102 otolaryngology/facial plastic surgery providers in California.

See all otolaryngology/facial plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$117,720
Medicare patients
360
Services billed
1,235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl21$359
Fluticasone Propionate22$202
Cefdinir12$62

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →